No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CURV240517P10000
- 5.80
- 0.000.00%
15min DelayTrading Feb 29 09:37 ET
0.00High0.00Low
0.00Open5.80Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover845.61%IV-16.97%PremiumMay 17, 2024Expiry Date4.52Intrinsic Value100Multiplier4DDays to Expiry1.28Time Value100Contract SizeAmericanOptions Type-0.5574Delta0.0749Gamma1.01Leverage Ratio-0.2388Theta-0.0009Rho-0.56Eff Leverage0.0025Vega
Intraday
- 5D
- 1D
News
Investors Could Be Concerned With Torrid Holdings' (NYSE:CURV) Returns On Capital
What Torrid Holdings Inc.'s (NYSE:CURV) 27% Share Price Gain Is Not Telling You
Those holding Torrid Holdings Inc. (NYSE:CURV) shares would be relieved that the share price has rebounded 27% in the last thirty days, but it needs to keep going to repair the recent damage it has ca
TORRID ANNOUNCES 2024 CASTING CALL AND TOUR ACROSS AMERICA IN SEARCH OF ITS NEXT BRAND MODEL
Express News | Shares of Companies Within the Broader Consumer Discretionary Sector Are Trading Lower Amid Overall Market Weakness on Rate Cut Uncertainty
Torrid Holdings' Dividend Dilemma: Investor Attraction at Risk Amidst Payment Uncertainty and Debt Constraints
Morgan Stanley Adjusts Torrid Price Target to $5 From $4, Maintains Equal Weight Rating
Morgan Stanley Adjusts Torrid Price Target to $5 From $4, Maintains Equal Weight Rating.
Comments
4/1/2024 🦍’s Watchlist 🚨⚡️🚨⚡️🚨⚡️🚨
$Yield10 Bioscience(YTEN.US$ $Lytus Technologies Holdings(LYT.US$ $Avalo Therapeutics(AVTX.US$ $Gamida Cell(GMDA.US$ $Torrid(CURV.US$ $Qilian International(QLI.US$
📊⚡️📊
$Yield10 Bioscience(YTEN.US$ $Lytus Technologies Holdings(LYT.US$ $Avalo Therapeutics(AVTX.US$ $Gamida Cell(GMDA.US$ $Torrid(CURV.US$ $Qilian International(QLI.US$
📊⚡️📊
3
ColumnsTorrid Holdings Gains More Than 25% After Hours After Plus-Sized Clothier Reports Narrower Q4 Loss
$Torrid(CURV.US$ rose more than 25% after hours Thursday after the plus-sized clothing maker beat analyst estimates for Q4 revenues and overall results.
CURV soared 26% to trade at $6.15 shortly before 4:45 p.m. ET after the company reported a $0.04 loss per share – narrower than the $0.07 analysts had reportedly expected.
The company also recorded $293.5 million of quarterly revenues vs. the $276....
CURV soared 26% to trade at $6.15 shortly before 4:45 p.m. ET after the company reported a $0.04 loss per share – narrower than the $0.07 analysts had reportedly expected.
The company also recorded $293.5 million of quarterly revenues vs. the $276....
2
The declining ROCE and revenue despite increased capital deployment is a concerning trend for Torrid Holdings. While the stock has performed well over the past year, these underlying trends do not bode well for its long-term performance.
Read more